Creative Planning
ANTH

Creative Planning’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Creative Planning’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-148
Closed – – 4420
2017
Q2 		$0 Sell
148
-1
-0.7% -$2 ﹤0.01% 5004
2017
Q1 		$1K Hold
149
– – ﹤0.01% 4578
2016
Q4 		$1K Hold
149
– – ﹤0.01% 4561
2016
Q3 		$4K Sell
149
-101
-40% -$2.55K ﹤0.01% 4035
2016
Q2 		$6K Hold
250
– – ﹤0.01% 3580
2016
Q1 		$7K Buy
250
+125
+100% +$3.39K ﹤0.01% 3450
2015
Q4 		$5K Hold
125
– – ﹤0.01% 3730
2015
Q3 		$6K Buy
+125
New +$8.73K ﹤0.01% 3554
2014
Q3 		– Sell
-250
Closed -$7K – 4249
2014
Q2 		$7K Buy
+250
New +$6.17K ﹤0.01% 3078

Other funds holding ANTH

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Creative Planning's ANTH Position: Q3 2017 in Review

Creative Planning sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2017, closing a stake of 148 shares.

Creative Planning first reported a position in ANTH in Q2 2014 and held it in 9 quarters. The position peaked at $7K in Q1 2016. 35 funds tracked by Wall St. Rank hold ANTH as of Q3 2017.

  • Creative Planning reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 148 Anthera Pharmaceuticals, Inc. shares in Q3 2017.
  • Creative Planning first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2014 and held it in 9 quarters.
  • Creative Planning's Anthera Pharmaceuticals, Inc. position peaked at $7K in Q1 2016.
  • 35 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.